Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-12-31 Sale |
2025-01-03 4:08 pm |
Arcus Biosciences Inc. | RCUS | Goeltz II Robert C. Chief Financial Officer |
3,594 | $15 | $53,910 | 60,138 (Direct) |
View |
| 2024-01-02 Sale |
2024-01-04 5:23 pm |
Arcus Biosciences Inc. | RCUS | Goeltz II Robert C. Chief Financial Officer |
2,004 | $20 | $40,080 | 51,831 (Direct) |
View |
| 2023-12-18 Sale |
2023-12-20 4:10 pm |
Arcus Biosciences Inc. | RCUS | Goeltz II Robert C. Chief Financial Officer |
5,557 | $17.92 | $99,564 | 53,835 (Direct) |
View |
| 2023-06-07 Sale |
2023-06-09 4:05 pm |
Arcus Biosciences Inc. | RCUS | Goeltz II Robert C. Chief Financial Officer |
4,049 | $20.04 | $81,142 | 59,392 (Direct) |
View |
| 2022-12-16 Sale |
2022-12-16 9:44 pm |
Arcus Biosciences Inc. | RCUS | Goeltz II Robert C. Chief Financial Officer |
2,453 | $30.75 | $75,430 | 11,566 (Direct) |
View |
| 2021-12-16 Sale |
2021-12-20 4:22 pm |
Arcus Biosciences Inc. | RCUS | Goeltz II Robert C. Chief Financial Officer |
1,106 | $40.12 | $44,376 | 7,019 (Direct) |
View |
| 2020-09-09 Purchase |
2020-09-09 4:53 pm |
Arcus Biosciences Inc. | RCUS | Goeltz II Robert C. Chief Financial Officer |
5,000 | $21.57 | $107,849 | 5,000 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-23 Option Award |
2025-01-27 4:30 pm |
N/A 2025-01-22 |
Arcus Biosciences Inc. | RCUS | Goeltz II Robert C. Chief Financial Officer |
187,000 | $0 | 247,138 (Direct) |
View |
| 2024-12-15 Tax Withholding |
2024-12-17 8:36 pm |
N/A N/A |
Arcus Biosciences Inc. | RCUS | Goeltz II Robert C. Chief Financial Officer |
10,099 | $16.08 | 63,732 (Direct) |
View |
| 2024-01-23 Option Award(A) |
2024-02-23 5:49 pm |
N/A N/A |
Arcus Biosciences Inc. | RCUS | Goeltz II Robert C. Chief Financial Officer |
22,000 | $0 | 73,831 (Direct) |
View |
| 2024-01-23 Option Award |
2024-01-25 7:40 pm |
N/A 2034-01-22 |
Arcus Biosciences Inc. | RCUS | Goeltz II Robert C. Chief Financial Officer |
107,900 | $0 | 159,731 (Direct) |
View |
| 2023-01-23 Option Award |
2023-01-25 5:53 pm |
N/A 2033-01-22 |
Arcus Biosciences Inc. | RCUS | Goeltz II Robert C. Chief Financial Officer |
172,200 | $0 | 201,641 (Direct) |
View |
| 2022-03-08 Option Award |
2022-03-10 5:08 pm |
N/A 2032-03-07 |
Arcus Biosciences Inc. | RCUS | Goeltz II Robert C. Chief Financial Officer |
78,000 | $0 | 85,019 (Direct) |
View |
| 2021-01-19 Option Award |
2021-01-20 4:10 pm |
N/A 2031-01-18 |
Arcus Biosciences Inc. | RCUS | Goeltz II Robert C. Chief Financial Officer |
87,500 | $0 | 92,500 (Direct) |
View |
| 2020-08-03 Option Award |
2020-08-04 6:53 pm |
N/A 2030-07-31 |
Arcus Biosciences Inc. | RCUS | Goeltz II Robert C. Chief Financial Officer |
250,000 | $0 | 250,000 (Direct) |
View |
Ownership |
2020-08-04 6:15 pm |
N/A N/A |
Arcus Biosciences Inc. | RCUS | Goeltz II Robert C. Chief Financial Officer |
0 | $0 | 0 (Direct) |
View |
| 2020-06-22 Tax Withholding |
2020-06-24 5:03 pm |
N/A N/A |
Unity Biotechnology Inc. | UBX | Goeltz II Robert C. Chief Financial Officer |
2,483 | $9.67 | 161,027 (Direct) |
View |